Loss (0.16) beats the street of (0.23)... (only 2 estimates) so thats good. Lots of positives about market expansion. July best month in sales. Q2 revenue $2.2 million. Big loan to consolidate debt and pay PSIVDA their $25mil when FDA approves the labeling. But it appears nobody cares. no questions; was anybody listening? I own 31500 shares and will hold until it takes off in September AFTER fda APPROVES. There is only good news and nobody cares!! Am I all alone?? Wonder what the light of day will bring? This stock doesn't really need FDA approval to be a strong profitable company. It has the rest of the world!!!!
I think that the turnover for Q2 and the Development in Germany was a bit disappointing and also I would have liked to hear that the launch in France were moving a bit faster. But, I am alos working in this industry and know that it is not possible to force decisions on reimbursement and pricing of the product.
I have a lot of shares of Alimera and I believe or hope that we will see a run up in the period up to 2014/09/26... I have not yet decided if I will hold or not hold my shares during the FDA decision - I have tried this 2 times before , respectively for alimera and Psivida ....:-)
Bohn, glad to see you're still around. I'm in a similar boat-I tripled my shares of psdv, but not sure if I want to hold all of them to pdufa. I sure hope we get the run up that most of us are anticipating. Good luck to you!